VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor.
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor. Blood. 2006 Aug 15; 108(4):1174-82.
View in:
PubMed
subject areas
Acetylation
Antibiotics, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Cell Cycle
Cell Survival
Cyclin-Dependent Kinase Inhibitor p21
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Enzyme Inhibitors
Gene Expression Regulation, Leukemic
Histone Deacetylase Inhibitors
Histone Deacetylases
Histones
HL-60 Cells
Humans
Hydroxamic Acids
Idarubicin
Leukemia
Protein Processing, Post-Translational
RNA, Messenger
Valproic Acid
authors with profiles
CARLOS E BUESO-RAMOS
GUILLERMO GARCIA-MANERO
HUI YANG